Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company is headquartered in Los Angeles, California. The company went IPO on 2024-12-16. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The firm has not commenced any operations. The firm has not generated any revenues.
Oaktree Acquisition III Life Sciences Corp 的關鍵財務報表是什麼?
根據最新的財務報表(Form-10K),Oaktree Acquisition III Life Sciences Corp 的總資產為 $0,淨損失為 $0
OACC 的關鍵財務比率是什麼?
Oaktree Acquisition III Life Sciences Corp 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Oaktree Acquisition III Life Sciences Corp 的收入按細分市場或地理位置如何劃分?
Oaktree Acquisition III Life Sciences Corp 最大收入來源為 Japan,在最近的收益報告中收入為 138,108,000,000。就地區而言,Japan 是 Oaktree Acquisition III Life Sciences Corp 的主要市場,收入為 143,753,000,000。
Oaktree Acquisition III Life Sciences Corp 是否盈利?
無,根據最新的財務報表,Oaktree Acquisition III Life Sciences Corp 的淨損失為 $0
Oaktree Acquisition III Life Sciences Corp 有負債嗎?
無,Oaktree Acquisition III Life Sciences Corp 的負債為 0
Oaktree Acquisition III Life Sciences Corp 的流通股有多少?
Oaktree Acquisition III Life Sciences Corp 的總流通股為 0